EpigenCare logo

EpigenCare

Website
TwitterMore socials
Status
ICO

EpigenCare is a biotech company for personalized skincare by combining epigenetics and blockchain technology. EpigenCare creates a personalized skincare platform that combines epigenetic testing with ingredient-based algorithms to screen for brands that are best suited to the current quality of users’ skin.

EpigenCare White Paper Whitepaper

Important By investing in this business you agree to ourDisclaimer. All information including our rating, is provided merely for informational purposes. CryptoTotem does not provide investment advice.

Interest lvl
NA
Learn more about our rating
User Rating
Medium
3/5 1 votes
Claim your project
Ticker
EPIC
Type
Utility-token

What is EpigenCare

EpigenCare web platform empowers users with the knowledge of which products truly work for their skin. Instead of generalized marketing, companies will use EpigenCare matching system to market their brands to users based on their unique skin profile - if it's not qualified for their skin on a functionally biological level, it gets rejected. Matching is filtered by EpigenCare A.I. algorithm based on epigenetic, toxicity, and absorbance effects of the ingredients on the tested skin quality indicators. All EPIC token holders will receive 15% & 10% revenue distribution (payable as ETH) in the first two years of operation, respectively. Afterwards, EPIC holders will receive 5% quarterly of all revenue, including skincare test sales and product match sales.

EpigenCare Roadmap

1
Q2, 2017

EpigenCare Inc. Established in New York, USA

2
Q4 2017

Epigenetic-based Skincare Test Successfully Developed and Proven

3
Q1 2018

ICO Token Generation Event

4
Q2 2018

Launch Marketing Campaign for Product Pre-Orders

5
Q3 2018

Limited Launch of Beta Skincare Test

6
Q4 2018

Full Skincare Test Launch to Public; Launch EpigenCare Network Open Beta

7
Q1 2019

Launch Consumer Mobile Application

8
Q2 2019

Launch Official EpigenCare Network Platform

9
Q3 2019

Retail Distribution Initiative; Deploy API (Application Programming Interface)

10
Q4 2019

Dermatologist/Spa/Beauty Salon Partnership Initiative

11
Future Objectives

Integrate Deep-Learning Artificial Intelligence Elements Based on Epigenetic Skin Data; Develop Complementary A-I-Based Mobile Imaging Application

Token Sale Dates

Presale Period

Start date: Mar 19, 2018
End date: Apr 15, 2018

ICO

Start date: Apr 16, 2018
End date: Jul 31, 2018

Token Allocation

Total Token Supply 60,000,000

Funding Details

Hard Cap 20,000,000 USD(fiat)

Token distribution


83.3% - Crowdsale Supply
10%  -Founders
6.2% - Key Employees
0.5% - Advisory Team

Funds allocation


50% - Product Development & Operations
35% - Marketing & Business Development:
10% - Administration
5% - Legal

Project team

William Lee
William Lee
Chief Executive Officer
William Lee linkedin-team
Adam Weiwei Li, Md, Ph.d.
Adam Weiwei Li, Md, Ph.d.
Chief Scientific Officer
Adam Weiwei Li, Md, Ph.d. linkedin-team
Jessica Li
Jessica Li
Chief Financial Officer
Jessica Li linkedin-team
Ashley Pottash
Ashley Pottash
Business Strategy Lead
Ashley Pottash linkedin-team
Stephen Fiser
Stephen Fiser
Software Development Lead
Stephen Fiser linkedin-team

Advisors

Richard Wildnauer, Ph.D.
Richard Wildnauer, Ph.D.
Business Advisor
Richard Wildnauer, Ph.D. linkedin-team
James Wang, MD
James Wang, MD
Dermatology Advisor
James Wang, MD linkedin-team
Brennan Bennett
Brennan Bennett
Blockchain Advisor
Brennan Bennett linkedin-team
Rebecca Fry, Ph.D.
Rebecca Fry, Ph.D.
Epigenetics Advisor
Rebecca Fry, Ph.D. linkedin-team
Tim Bukher
Tim Bukher
Legal Strategy Advisor

Social media

Industries

Leave a Reply

Your email address will not be published. Required fields are marked *

listing on exchanges

Leave a Reply

Your email address will not be published. Required fields are marked *

Sponsored Crypto Projects

KYMAi (KYMAI) logo
KYMAi (KYMAI) Sponsored
KYMAi (KYMAI)
Low
ICO
NOCtura (NOC) logo
NOCtura (NOC) Sponsored
NOCtura (NOC)
Low
ICO
Zama (ZAMA) logo
Zama (ZAMA)
High
ICO
IEO

Newly Published